Since 1992, the 340B drug discount program has entitled certain federal grantee clinics and hospitals (called “covered entities”) to purchase outpatient drugs at substantial discounts. The discounted ...
AHA urges HRSA to axe 340B model that would cost hospitals over $1 billion annually and increase administrative burdens.
Accountable Care Organization stakeholders are applauding the capitation payments in the new ACO Primary Care Flex Model but lament that it leaves out high-revenue ACOs. The Centers for Medicare and ...
Economic Analysis of Screening, Diagnostic, and Treatment Technologies for Cancer: Reflections and a Roadmap for Prospective Authors On June 27, 2022, the Centers for Medicare and Medicaid Services' ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results